Epidemiologist stresses COVID-19 pathophysiologic research
chinadaily.com.cn |
Updated: 2020-03-19 08:00
Share
Share - WeChat
More research should be done on the overreaction of the immune response in COVID-19 disease, said Zhong Nanshan, China's leading epidemic control expert, in a recent video talk.
Zhong also noted that once the patients deteriorate, the survival rate is pretty low, as some of the pathophysiologic characteristics are different from usual cases of ARDS, or acute respiratory distress syndrome.
Zhong shared China's experience in the fight against the coronavirus with Dr. Anita Simonds, the president-elect of the European Respiratory Society, in an online conversation earlier this month.
- China launches first national standard on school meal services
- China's nano 'two-photon factory' sets world record
- Low-altitude transit route links Shanghai, Jiangsu
- Shanghai-Hong Kong Youth Choir Festival launches
- Chinese courts step up efforts to safeguard stability
- Former tech group executive sentenced for bribery
